Medicinova, Inc. (MNOV)

Price$1.31

Value ScoreD

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-17.58%

Price vs S&P 500 (4W)-6.42%

VGM Score41.73

Market Capitalization$64.48M

All Metrics

Book Value / Share (Quarterly)$0.80

P/TBV (Annual)1.75x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.19

Price vs S&P 500 (YTD)-8.16%

Gross Margin (TTM)8.03%

Net Profit Margin (TTM)-1964.15%

EPS (TTM)$-0.24

10-Day Avg Trading Volume0.03M

EPS Excl Extra (TTM)$-0.24

EPS (Annual)$-0.24

ROI (Annual)-28.85%

Gross Margin (Annual)7.58%

Net Profit Margin (5Y Avg)-1094.76%

Cash / Share (Quarterly)$0.56

ROA (Last FY)-26.31%

EBITD / Share (TTM)$-0.26

ROE (5Y Avg)-19.16%

Operating Margin (TTM)-2165.33%

Cash Flow / Share (Annual)$-0.20

P/B Ratio1.64x

P/B Ratio (Quarterly)1.71x

Net Income / Employee (Annual)$-1,999,700

EV / Revenue (TTM)62.27x

Net Interest Coverage (TTM)-10.07x

ROA (TTM)-25.22%

EPS Incl Extra (Annual)$-0.24

Current Ratio (Annual)8.16x

Quick Ratio (Quarterly)8.91x

3-Month Avg Trading Volume0.04M

52-Week Price Return-5.76%

Revenue / Employee (TTM)$99,400

Tangible BV / Share (Quarterly)$0.70

P/S Ratio (Annual)157.40x

Asset Turnover (Annual)0.01x

52-Week High$1.96

Operating Margin (5Y Avg)-1184.24%

EPS Excl Extra (Annual)$-0.24

CapEx CAGR (5Y)-40.83%

Tangible BV CAGR (5Y)-11.17%

26-Week Price Return-9.66%

Quick Ratio (Annual)8.11x

13-Week Price Return0.77%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)9.09x

Enterprise Value$37.15M

Asset Turnover (TTM)0.01x

Book Value / Share Growth (5Y)-11.82%

Revenue / Employee (Annual)$68,300

Pretax Margin (Annual)-2927.30%

Cash / Share (Annual)$0.63

3-Month Return Std Dev48.11%

Gross Margin (5Y Avg)36.04%

Net Income / Employee (TTM)$-1,953,200

ROE (Last FY)-28.85%

Net Interest Coverage (Annual)342.00x

EPS Basic Excl Extra (Annual)$-0.24

Receivables Turnover (TTM)0.00x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.24

ROI (TTM)-27.26%

P/S Ratio (TTM)108.07x

Pretax Margin (5Y Avg)-1094.13%

Revenue / Share (Annual)$0.01

Tangible BV / Share (Annual)$0.75

Price vs S&P 500 (52W)-30.13%

Year-to-Date Return0.00%

5-Day Price Return-4.38%

EPS Normalized (Annual)$-0.24

ROA (5Y Avg)-17.91%

Net Profit Margin (Annual)-2928.76%

Month-to-Date Return-3.68%

Cash Flow / Share (TTM)$-0.19

EBITD / Share (Annual)$-0.27

Operating Margin (Annual)-3242.44%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-19.16%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.24

P/TBV (Quarterly)1.95x

P/B Ratio (Annual)1.55x

Pretax Margin (TTM)-1963.15%

Book Value / Share (Annual)$0.84

Price vs S&P 500 (13W)-7.49%

Beta0.64x

P/FCF (Annual)78.63x

Revenue / Share (TTM)$0.01

ROE (TTM)-27.26%

52-Week Low$1.17

vGradeD

mGradeC

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-0.05est. -0.07

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.14

4.13

4.10

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
MNOVMedicinova, Inc.	D	—	C	$1.31
LLYEli Lilly & Co.	D	B	B	$1131.42
JNJJohnson & Johnson	D	C	B	$232.77
ABBVABBVIE INC.	D	C	C	$227.23
MRKMerck & Co., Inc.	C	C	B	$120.79
NVSNovartis AG	C	C	C	$149.16
AZNAstraZeneca PLC	D	B	C	$185.95
NVONovo-Nordisk A/S	B	B	B	$42.96
ABTAbbott Laboratories	C	C	D	$91.07
PFEPfizer Inc.	B	C	C	$26.04
BMYBristol-Myers Squibb Co.	B	C	B	$57.27

About

MediciNova is a biopharmaceutical company that develops small-molecule therapeutics for diseases with unmet medical needs, with particular focus on neurological disorders and fibrotic diseases in the U.S. market. The company's pipeline includes candidates such as MN-001, MN-166, and MN-221, developed through a strategy of acquiring and advancing promising therapeutic assets.